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Abstract: Prader–Willi syndrome is a rare genetic disorder associated with impaired body composition,
hyperphagia, and excessive weight gain. Strict dietary restrictions from an early age is crucial to
prevent or delay the early onset of obesity, which is the main driver of comorbidities in these
patients. The aim of this study was to identify dietary and gut microbiota components closely linked
to weight status of these patients. We studied a cohort of children and adolescents with genetic
diagnosis of Prader–Willi syndrome (N = 31), in which we determined adiposity by Dual-energy
X-ray absorptiometry (DXA) and dietary composition with 4-day food records. Furthermore, we
obtained fecal samples to assess microbiota composition by 16S sequencing. Multivariate regression
models showed that body mass index standard deviation score (BMI-SDS) and body fat mass were
directly associated with saturated fat intake and meat consumption, and inversely associated with
fruit consumption. Furthermore, the gut microbiome from normal weight patients was characterized
by higher phylogenetic diversity compared to those overweight or obese, with differential abundance
of several genera, including Alistipes, Klebsiella, and Murimonas. Notably, Alistipes abundance was
inversely correlated to adiposity, lipid and glucose homeostasis parameters, and meat intake. Our
results suggest that limiting meat and increasing fruit intake might be beneficial for body weight
management in children and adolescents with Prader–Willi syndrome.
Keywords: Prader–Willi syndrome; childhood obesity; adiposity; dietary intake; gut microbiota
1. Introduction
Prader–Willi syndrome (PWS) is a rare genetic disorder that is caused by lack of expression of
paternal inherited genes located in the chromosome 15q11-q13 region [1]. The disease is present in
1:10,000–20,000 individuals and its most frequent genetic mechanisms are deletions in the paternal
chromosomal region (approximately 65%–75% of cases) followed by maternal disomy of chromosome 15
(approximately 20%–30% of cases); other less frequent causes include imprinting defects or translocations
in that chromosomal region [1]. PWS is characterized by a wide range of developmental and behavioral
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disturbances, including hypogonadism and hormonal dysfunction, hyperphagia, hypotonia, altered body
composition (higher fat and lower lean mass), short stature, as well as dysmorphic features [1]. A complex
hypothalamic dysregulation is currently thought to be responsible for this phenotype.
Regardless of the genetic origin, pediatric patients show a very characteristic progression through
different nutritional phases [2]. Feeding difficulties usually accompanied by failure to thrive appear
during the first months of life. These are followed by a period of normal-rate weight gain until
approximately two years of age. After this phase, weight gain starts steadily increasing even without a
change in energy intake. At around four years of age, patients start showing increased appetite and
interest in food, which precede the onset of hyperphagia [2]. Together with the insatiable hunger,
aberrant behaviors typically occur in this latter phase, including food seeking behavior, constant
thinking about food, withdrawn-depression symptoms, and social problems [3]. Therefore, these
patients require close supervision by caregivers and strict food access control, with consequent negative
effects on their quality of life and important distress for both patients and families.
The occurrence of both abnormal body composition (reduced lean mass) and insatiable hyperphagia
leads to reduced energy expenditure and increased caloric intake, respectively, favoring energy
accumulation and resulting in excess of adiposity [4]. In fact, PWS is the most common cause of
genetic obesity. Obesity is the main driver of comorbidities in these patients, including respiratory
difficulties, sleep apneas, hypertension, steatohepatitis, and type 2 diabetes, responsible for their premature
mortality [5]. Thus, one of the main goals of therapeutic strategies is preventing or delaying the early
onset of obesity in order to change its clinical progression. Current management strategies include
early interventions involving physical and cognitive stimulation, growth hormone therapy, and early
dietary recommendations. Based on their lower energy requirements, these recommendations include
limiting caloric intake by 20%–40%, together with a well-balanced macronutrient distribution and
high fiber intake [1,4,6–8]. However, despite noticeable improvements in care during the last decade,
adequate weight control continues to be extremely challenging and patients often develop obesity and
associated complications. The gut microbiome has emerged as an important player in determining
host health and energy balance [9,10]. Its composition is highly affected by diet [11,12], and several
studies have shown a causative role of microbiota in developing obesity [10,13]. However, research on
the gut microbiome in subjects with PWS is very scarce. To date, only two studies have compared the
microbiome of subjects with PWS with obesity and controls also with obesity [8,14].
In this study, we aimed to identify dietary components closely linked to weight status and
adiposity in children and adolescents with PWS. Furthermore, we analyzed the gut microbiome in
these subjects to shed more light into the interrelationship between diet, gut microbiome, and obesity
in this population.
2. Materials and Methods
2.1. Human Subjects
This study was approved by the Hospital’s ethical committee (code number PIC-73-17).
Participants were recruited at the Hospital Sant Joan de Déu (Barcelona, Spain) and Parc Taulí
Hospital Universitari (Sabadell, Spain), from September 2017 to June 2018. Both hospitals are reference
centers for this disease in Catalonia. Inclusion criteria were genetic confirmation of PWS, age between
4.5 and 18-years-old, and absence of any major cognitive disorder that could preclude participation in
the study. All parents signed the informed consent form; additionally, patients older than 12 years
of age provided written informed assent. All participants except for one were on growth hormone
therapy. Subjects had been patients at the hospital for at least one year before the study, and parents
were proficient in nutrition and care related to PWS at the time of the study. Also, given that this
disease is characterized by low muscle tone and patients are significantly more sedentary than the
general population, we encourage enrollment in physical activity programs, which mostly includes
individual sports (especially dance classes, swimming, and tennis).
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2.2. Physiologic and Metabolic Variables
Fasting blood tests and anthropometric measurements were obtained at the study visit. A stool
sample obtained up to 48 h before was also collected at this time. Weight and height were determined
with a digital scale and stadiometer by a qualified nurse. Body composition was determined on a
Prodigy Lunar® DXA scanner (Lunar Corp., Madison, WI, USA). Age- and sex-adjusted body mass
index standard deviation scores (BMI-SDS) were calculated using WHO AnthroPlus software (World
Health Organization, Geneva, Switzerland) [15]. Blood biochemical measurements were performed
at the hospital laboratory following standard procedures. Homeostatic model assessment of insulin
resistance (HOMA-IR) was calculated as described previously [16]. Hyperphagia levels were assessed
with the Hyperphagia Questionnaire for Clinical Trials (HQ-CT), a nine-question questionnaire (score
0-36) developed for patients with PWS.
2.3. Dietary Analysis
Parents filled a 4-day food diary (three weekdays and one weekend day) during the week prior
to the study visit. Food records were discussed in a personal interview with the nutritionist during
the study visit, where portion sizes and cooking methods were detailed. Participants were taking no
probiotic or prebiotic supplements. Reviewed records were then analyzed with DIAL software [17],
providing the macro- and micro-nutrient composition of the diet, as well as the average daily intake of
different food groups. Considered food groups included grains, legumes, vegetables, fruit, meat, fish,
dairy, eggs, oils and fat, and beverages (sodas and juices), and were calculated as % of total calorie
intake. Energy intake was calculated as daily calorie intake and as % of daily recommended caloric
intake (RCI) for each patient, based on age-, gender-, and BMI-matched subjects.
2.4. Gut Microbiota Analysis
DNA from stool samples was isolated following Yuan et al. [18] with minor modifications, with
the aid of QIAamp PowerFecal DNA Kit (Qiagen, Hilden, Germany) to avoid bias in DNA purification
toward misrepresentation of gram-positive bacteria. For massive sequencing, the hypervariable
region V3-V4 of the bacterial 16s gene was amplified using key-tagged eubacterial primers [19] and
was sequenced with a MiSeq Illumina Platform (Illumina, Sant Diego, CA, USA) following Illumina
recommendations for library preparation and sequencing for metagenomics studies. An average of
85,000 reads per sample were obtained. The resulting sequences were split taking into account the
barcode introduced during the PCR reaction, while R1 and R2 reads were overlapped using PEAR
program version 0.9.125 providing a single FASTQ file for each of the samples. Quality control of the
sequences was performed in different steps. First, quality filtering (minimum threshold of Q20) was
performed using fastx tool kit version 0.013. Next, primer (16s rRNA primers) trimming and length
selection (reads over 300nts) was done with cutadapt version 1.4.126. These FASTQ files were then
converted to FASTA files, and UCHIME program version 7.0.1001 was used to remove chimeras that
could arise during the amplification and sequencing step. Those clean FASTA files were BLAST27
against the National Center for Biotechnology Information (NCBI) 16s rRNA database using blastn
version 2.2.29+. The resulting XML files were processed using a python script developed by ADM
Lifesequencing (Valencia, Spain) to annotate each sequence at different phylogenetic levels.
2.5. Statistical Analysis
Data are shown as mean and standard deviation (SD) or n and percentage (%) for continuous
and categorical variables, respectively. Student’s t-test or Chi-square test for continuous or categorical
variables were used for group comparisons. Multivariate linear least-squares regression was applied
to assess associations between % fat mass or BMI-SDS (dependent variables) and dietary variables
(independent variables), adjusted by sex, age, physical activity, genotype, metformin use, and energy
intake. Results are shown as effect size (B) with 95% confidence intervals (CI). For microbiome analysis,
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DESeq2 package from R (R Core Team, 2012) was used to generate a generalized linear model with
fixed effects with negative binomial family to compare operational taxonomic unit (OTU) counts
between groups, using group (normal weight (NW) and overweight or obesity (OWO)) as a fixed effect.
Count normalization was made by rarefaction and significance assessed with the Wald test and the
Benjamini–Hochberg correction to adjust for false discovery rate (FDR). Spearman correlation was
used to assess associations of physiologic and dietary variables with the selected genus. A p < 0.05 was
considered significant. Analyses were performed in JMP® v14.3 (SAS, Cary, NC, USA).
3. Results
3.1. Subject Characteristics
Demographic and metabolic characteristics of participants are described in Table 1. Our cohort
included 31 subjects (19 female and 12 male) within a range of ages (5 to 18 years-old) and BMI-SDS
(−1.24 to 4.5 standard deviations). Subjects were divided into normal weight (NW, n = 12) and
overweight or obesity (OWO, n = 19) groups based on BMI-SDS below or over 1 standard deviation,
respectively, following the WHO criteria for overweight and obesity. Groups showed no differences
in age, genotype distribution, or hyperphagia levels; a slightly higher proportion of female subjects
and patients with metformin therapy was included in the OWO group (p = 0.075 and p = 0.061,
respectively). Fifty-five per cent of subjects in our cohort performed more than 2 h per week of exercise,
and there were no differences between NW and OWO groups. As expected, patients from the OWO
group had significantly higher BMI-SDS and body fat mass than NW patients (Table 1). Although
in general subjects showed a normal lipid profile (triglycerides <150 mg/dL, low-density lipoprotein
(LDL)-cholesterol <130 mg/dL) [20], patients in the OWO group had higher LDL-cholesterol (p = 0.036)
and a trend towards increased total cholesterol (p = 0.069) compared to the NW group (Table 1). Fasting
glucose and HbA1c were also within the normal range in both groups (glucose <100 mg/dL, HbA1c
<6%), while insulin levels were on the higher end of the normal range for our laboratory reference
values. When comparing both groups, fasting insulin levels and HOMA-IR were two-fold higher in
OWO than in NW group (p < 0.05 for both; Table 1), indicating some degree of insulin resistance in
children and adolescents with overweight and obesity compared to normal weight patients.
Table 1. Demographic and metabolic characteristics of participants.




(n = 19) p-Value
a
Gender (Females) 19 (61%) 5 (42%) 14 (74%) 0.075
Age (years) 12.0 (4.0) 11.4 (3.9) 12.4 (4.2) 0.498
Pre-pubertal status 12 (39%) 6 (50%) 6 (32%) 0.306
Genotype (Deletions) 18 (58%) 5 (42%) 13 (68%) 0.243
Hyperphagia (HQ-CT Score) 6.8 (6.0) 7.3 (7.4) 6.6 (5.1) 0.787
Physical activity (>2 h/week) 17 (55%) 8 (67%) 9 (47%) 0.290
Growth hormone therapy 30 (97%) 12 (100%) 18 (95%) 0.317
Metformin therapy 8 (26%) 1 (8%) 7 (37%) 0.061
BMI-SDS 1.51 (1.38) 0.22 (0.55) 2.32 (1.09) <0.001
Body fat mass (%) 43.2 (8.4) 35.9 (3.9) 47.9 (7.0) <0.001
Lipid profile
Triglycerides (mg/dL) 70 (25) 64 (26) 74 (25) 0.294
Cholesterol (mg/dL) 170 (36) 155 (34) 179 (35) 0.069
LDL-cholesterol (mg/dL) 102 (31) 88 (30) 112 (28) 0.036
HDL-cholesterol (mg/dL) 56 (13) 55 (13) 58 (14) 0.529
Glucose metabolism
Glucose (mg/dL) 87 (9) 85 (10) 88 (9) 0.352
HbA1c (%) 5.3 (0.2) 5.2 (0.3) 5.3 (0.2) 0.692
Insulin (mU/L) 12.6 (9.2) 8.0 (7.2) 15.6 (9.3) 0.017
HOMA-IR 2.82 (2.18) 1.76 (1.62) 3.49 (2.26) 0.020
Data are shown as mean and standard deviation (SD) for continuous variables and n and percentage (%) for
categorical variables. a, group differences were assessed with Student’s t-test (continuous variables) or Chi-square
test (categorical variables). Bold font represents p < 0.05. HQ-CT, hyperphagia questionnaire for clinical trials;
BMI-SDS, body mass index standard deviation score; LDL, low-density lipoprotein; HDL, high-density lipoprotein;
HOMA-IR, homeostatic model assessment of insulin resistance.
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3.2. Dietary Analysis of Children and Adolescents with Prader–Willi Syndrome
The dietary analysis revealed that energy intake was 80% the recommended caloric intake (RCI), in
agreement with the recommendations for PWS (Table 2). Macronutrient distribution analysis showed
a well-balanced diet within the recommended ranges [21]. Interestingly, we observed no differences in
energy intake between OWO and NW groups (Table 2). Similarly, there were no major differences in
macronutrient distribution or fiber intake, although diet from OWO subjects was slightly higher in
fat and lower in carbohydrates than the diet from NW patients (Table 2). Regarding micronutrients,
while intake of iron, folic acid, and vitamins A, B6, B12, and E achieved the recommended intake
level, calcium and vitamin D were significantly below the threshold (Figure S1a). No differences in
micronutrient intake were observed between NW and OWO groups (Figure S1b).
Table 2. Dietary intake analysis of participants.




n = 19 p-Value
Energy Intake (kcal/day) 1571 (349) 1525 (308) 1600 (378) 0.552
(% RCI) 80 (22) 84 (26) 78 (20) 0.493
Protein (% kcal) 17.7 (2.7) 17.3 (2.7) 18.0 (2.9) 0.530
Fat (% kcal) 32.7 (6.0) 31.1 (6.1) 33.7 (5.9) 0.256
SFA (% kcal) 9.4 (2.6) 8.6 (2.7) 9.9 (2.4) 0.170
MUFA (% kcal) 14.9 (2.7) 14.1 (2.8) 15.4 (2.6) 0.198
PUFA (% kcal) 5.1 (1.3) 5.2 (1.2) 5.0 (1.3) 0.727
Carbohydrate (% kcal) 46.6 (5.6) 48.2 (4.6) 45.5 (6.0) 0.176
Fiber (g/day) 23.8 (12.0) 24.9 (10.0) 23.1 (13.4) 0.681
MRI, macronutrient recommended intake; NW, normal weight; OWO, overweight and obesity; RCI, recommended
caloric intake; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
Data are shown as mean and SD. Group differences were assessed with Student’s t-test.
Regarding intake of the different food groups, normal weight patients showed significantly higher
fruit and lower meat intake than those overweight or obese (Table 3). Intake of other food groups,
including grains, legumes, vegetables, dairy, fish, eggs, oils and fats, and beverages were similar
between groups.
Table 3. Food group intake analysis of participants in the study.




n = 19 p-Value
Grains 27.6 (7.0) 25.6 (8.2) 29.0 (6.1) 0.235
Legumes 4.4 (3.6) 4.4 (4.4) 4.3 (3.2) 0.960
Vegetables 5.4 (2.1) 6.0 (2.0) 5.1 (2.1) 0.245
Fruit 11.8 (6.5) 14.6 (5.9) 10.0 (6.3) 0.050
Dairy 16.9 (6.6) 18.4 (8.3) 16.0 (5.2) 0.394
Meat 9.9 (5.8) 7.0 (3.8) 11.7 (6.3) 0.015
Fish 3.6 (1.7) 3.9 (1.7) 3.5 (1.8) 0.499
Eggs 1.7 (1.2) 1.8 (1.1) 1.7 (1.2) 0.946
Oils and fats 11.6 (2.6) 11.9 (3.0) 11.4 (2.4) 0.589
Beverages 1.6 (2.0) 1.6 (1.9) 1.7 (1.6) 0.899
NW, normal weight; OWO, overweight and obesity. Food group data are shown as mean and SD of % of total
calorie intake. Group differences were assessed with Student’s t-test. Bold font represents p < 0.05.
3.3. Associations between Dietary Variables and the Degree of Obesity
To identify dietary determinants of the degree of obesity in these patients, we applied multivariate
least-squares linear regression to assess potential associations between the different dietary variables
and BMI-SDS or % of body fat mass. We observed no association between total calorie intake and
BMI-SDS or adiposity (Table 4). Among macronutrients, only saturated fat intake was significantly
associated with both variables (Table 4). Although markedly weaker, carbohydrate intake showed an
inverse association with BMI-SDS (Table 4).
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Table 4. Associations between dietary variables and adiposity or BMI-SDS.
Dietary Variables
BMI-SDS Body Fat Mass (%)
B (CI 95%) p-Value B (CI 95%) p-Value
Caloric intake (kcal/day) a 0.00 (0.00 to 0.00) 0.293 −0.01 (−0.02 to 0.00) 0.133
Protein (% kcal) 0.11 (−0.11 to 0.33) 0.302 0.11 (−1.18 to 1.41) 0.856
Fat (% kcal) 0.08 (0.00 to 0.17) 0.061 0.44 (−0.06 to 0.94) 0.084
SFA (% kcal) 0.26 (0.06 to 0.47) 0.014 1.49 (0.31 to 2.67) 0.016
MUFA (% kcal) 0.16 (−0.02 to 0.35) 0.081 0.88 (−0.20 to 1.96) 0.105
PUFA (% kcal) −0.12 (−0.56 to 0.32) 0.571 −1.09 (−3.61 to 1.43) 0.379
Carbohydrates (% kcal) −0.09 (−0.18 to −0.01) 0.038 −0.39 (−0.92 to 0.14) 0.145
Fiber (g/day) −0.03 (−0.08 to 0.02) 0.168 −0.21 (−0.50 to 0.08) 0.144
Linear regression models were adjusted by sex, age, physical activity level, genotype, metformin use, and caloric
intake. a, model not adjusted by caloric intake. B, effect size from the multivariate regression model; CI, confidence
interval; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids. Bold
font indicates p < 0.05.
Regarding food groups, intake of grain, legume, vegetable, dairy, fish, eggs, oils and fats, or
beverages did not correlate to BMI-SDS or fat mass (Table 5). Notably, meat intake showed a direct
association with both BMI-SDS (p = 0.001) and body fat mass (p = 0.026) in these subjects, while
fruit intake was inversely associated with both variables (Table 5). In agreement with the nutritional
composition of these two food groups, meat consumption was correlated to saturated fat intake
(Pearson coefficient r = 0.41, p = 0.022) and fruit consumption was correlated to carbohydrate intake
(Pearson coefficient r = 0.43, p = 0.017).
Table 5. Associations between food group intake and BMI-SDS or adiposity.
Food Groups
BMI-SDS Body Fat Mass (%)
B (CI 95%) p-Value B (CI 95%) p-Value
Grains 0.03 (−0.04 to 0.11) 0.360 0.19 (−0.25 to 0.63) 0.375
Legumes −0.05 (−0.23 to 0.12) 0.535 −0.19 (−1.20 to 0.83) 0.707
Vegetables −0.22 (−0.48 to 0.04) 0.098 −0.64 (−2.21 to 0.93) 0.406
Fruit −0.12 (−0.2 to −0.04) 0.008 −0.64 (−1.14 to −0.14) 0.015
Dairy −0.01 (−0.11 to 0.08) 0.751 −0.08 (−0.62 to 0.47) 0.776
Meat 0.12 (0.05 to 0.20) 0.002 0.52 (0.05 to 0.99) 0.033
Fish −0.12 (−0.46 to 0.21) 0.459 −0.95 (−2.86 to 0.97) 0.318
Eggs 0.23 (−0.24 to 0.69) 0.329 1.45 (−1.24 to 4.15) 0.276
Oils and fat −0.05 (−0.27 to 0.17) 0.632 −0.03 (−1.31 to 1.26) 0.966
Beverages −0.17 (−0.44 to 0.11) 0.216 −0.38 (−2.01 to 1.25) 0.632
Model adjusted by sex, age, physical activity level, genotype, metformin use, and caloric intake. B, effect size from
the multivariate regression model; CI, confidence interval. Bold font indicates p < 0.05.
3.4. Gut Microbiota Composition in Children and Adolescents with Prader–Willi Syndrome
The analysis of the gut microbiota by 16S profiling showed higher phylogenetic diversity in
normal weight patients compared to those overweight or obese (Shannon index; Figure 1a). While
there were no major changes in community structure as shown by permutational analysis of variance
(PERMANOVA p = 0.146, Figure 1b), we observed differential abundance of seven microbial taxa
at the genus level in the categorical comparison between NW and OWO groups (Figure 1c). Three
genera had higher abundance in OWO compared to NW group, namely Klebsiella, Lactobacillus, and
Eubacterium, while genera Lachnoclostridium, Murimonas, Alistipes, and Prevotella had lower abundance
(Figure 1c). Three of these genera (Klebsiella, Murimonas, and Alistipes) were still significant after
correction for multiple comparisons (FDR adjusted p < 0.05). OTU abundance at genus level and fold
change between groups are listed in Table S1. Interestingly, we observed a gradation effect when
further subdividing OWO patients into overweight (1 ≤ BMI-SDS < 2) and obesity (BMI-SDS ≥ 2)
in both phylogenetic diversity and abundance of the selected genera (Figure S2). We next assessed
potential correlations between the selected genera and physiologic variables. Correlation coefficients
and significance levels are depicted in Table S2. Among them, lower Alistipes abundance was highly
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associated with higher body fat mass (Figure 1d). Furthermore, Alistipes was also inversely correlated
to total and LDL-cholesterol levels, as well as glucose homeostasis parameters including fasting insulin
levels and HOMA-IR (Figure 1d). Among the other genera, only Klebsiella showed a correlation to total
and LDL-cholesterol (Figure 1d). Notably, while fruit intake was not associated to abundance of any of
these genera, meat consumption was directly correlated to Eubacterium and inversely correlated to
Alistipes and Lachnoclostridium abundance.Nutrients 2020, 12, x FOR PEER REVIEW 8 of 13 
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4. Discussion
Dietary management is one of the critical aspects that determine health and quality of life in
patients with PWS. Based on their lower energy requirements, current dietary recommendations for
PWS are based on a 20%–40% caloric restriction [1,4,6]. Different types of calorie-restricted diets have
been proposed to improve weight management in patients with PWS [2,6,8,22]. In addition to energy
restrictionS, a well-balanced macronutrient distribution and high fiber content are also important
for successful weight control [7,8]. In agreement with the general recommendations, children and
adolescents from our cohort had an average of 20% calorie restriction in their diets, with a well-balanced
macronutrient distribution and a fairly high fiber intake. These patients also had an adequate intake of
micronutrients, except for calcium and vitamin D which were below the recommended intakes. Due to
the calorie restriction, dietary deficits in some micronutrients often occur in patients with PWS [23,24].
Nutrients 2020, 12, 1063 8 of 12
Interestingly, both calcium and vitamin D were also found to be below the recommended intake in a
US-based cohort of youth with PWS [24].
Our results showed no differences in hyperphagia scores or energy intake between normal weight
subjects and those overweight or obese, indicating that total calories were not contributing to obesity
in this population. These data are in agreement with a study by Miller et al. showing that a group
of children with PWS that followed a well-balanced macronutrient distribution diet achieved much
better weight control than another group that followed a simple energy-restricted diet, even when
both diets had similar caloric content [7]. All together, these data strongly suggest that diet quality
plays an important role in weight management of patients with PWS. Indeed, our results show that
those patients with lower meat and higher fruit consumption showed better weight management
independently of total calorie intake.
From observational investigations to longitudinal cohorts and intervention studies, a myriad of
studies has analyzed the dietary determinants of obesity in the general population. However, due to the
complex etiology of obesity with multiple genetic and environmental factors and confounders, research
has only been able to identify very few nutrients associated with weight management, including fiber,
fat, fruit and vegetable intake, sugar-rich drinks, or energy-dense micronutrient-poor foods [25–27].
It is worth mentioning that the parents of children with PWS are generally extremely involved in
their care and nutrition plan, as shown by the well-balanced macronutrient distribution in their diets.
Furthermore, sugary drinks or high-energy foods are practically absent from their diets, and most
likely do not significantly contribute to weight gain in these children.
While fat intake was once considered an important dietary determinant of obesity, a number of
studies have now shown only weak or no association of total fat intake with weight gain [28–30]. In
the Nurses’ Health Study, higher intake of saturated fat from animal origin showed a much stronger
association to weight gain than total fat intake [30]. Consistent with these data, we observed that
saturated fat intake was associated with both BMI-SDS and adiposity in our cohort. Saturated fat
and meat intake were correlated to each other in our cohort, indicating that meat was an important
source of saturated fat from animal origin. These data suggest that meat consumption might favor
energy accumulation in the context of PWS, in agreement with other studies that have linked meat
consumption, especially red and processed meat, with BMI in adult general population [31,32].
More consistent in the literature is the link between fiber intake and weight status [25], and
increasing dietary fiber content is a general recommendation for patients with PWS. In fact, higher
dietary fiber intake is associated with better weight management and weight loss in children and
adolescents with PWS [7,8]. In our study, we observed no association of fiber intake with BMI-SDS
or adiposity. This could be explained by the relatively high fiber content that was already present in
their diet. Increasing fruit and vegetable intake has also been favor as a strategy for weight loss [26].
While we observed no association of obesity with vegetable intake in our cohort, lower fruit intake
was correlated to higher BMI-SDS and adiposity.
During the last decade, an increasingly large number of studies have implicated the gut microbiome
in host energy homeostasis and body weight management [10,13,33]. However, only two studies have
examined the gut microbiome in subjects with PWS, both comparing the microbiota from patients
with PWS and obesity to controls with obesity [8,14]. A study in children with obesity found no
major differences in microbiota diversity and composition between patients with PWS and controls [8].
Conversely, a recent study in adult subjects with obesity observed higher phylogenetic diversity and
differential abundance of certain taxa in subjects with PWS compared to matched controls [14]. Several
factors could explain this apparent discrepancy between the studies, including different age-ranges
(children versus adults), geographical localization, and ethnicity. Furthermore, in the adult study no
differences in microbiota composition between subjects with PWS and their non-PWS parents were
observed [14], suggesting that diet and other environmental factors could be playing an important
role in determining gut microbiome structure. In our study, we compared the microbiome from
normal weight patients and overweight or obese patients in the context of PWS. Notably, we observed
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lower phylogenetic diversity in overweight and obese patients compared to patients with normal
weight. Indeed, decreased microbiota richness has been consistently associated with obesity and poor
metabolic health in the general population, including impaired glucose homeostasis and increased
adiposity [33,34].
Our study has identified several microbial taxa at the genus level associated with obesity status
in children and adolescents with PWS. Three of these genera sustained adjustment for multiple
comparisons, namely Klebsiella, Murimonas, and Alistipes. Among these genera, Alistipes showed a
highly significant inverse association with body fat mass and was also inversely correlated to cholesterol
levels and insulin resistance in our cohort. These data indicate that lower Alistipes abundance is linked to
a poor metabolic health phenotype, at least in the PWS context. Interestingly, other studies have found
lower Alistipes abundance in individuals with obesity compared to normal weight controls [35–38].
Furthermore, Alistipes was identified as a predictor of successful weight loss in a two-year intervention
in adult subjects with obesity [39]. Together with these data, our results support a potential beneficial
role of Alistipes in the context of obesity and metabolic health.
Our results showed that lower Alistipes abundance was also linked to higher meat intake. In fact,
diet is one of the main determinants of gut microbiota composition [11,12]. In patients with PWS,
Zhang et al. showed that a 30-day intervention with a diet rich in non-digestible carbohydrates led
to changes in the gut microbiome and improved body weight and metabolic health in children with
PWS [8]. By means of microbiota transplants into gnotobiotic mice, the authors demonstrated that
these changes in the microbiome contributed to the beneficial effects of the intervention [8]. Thus,
modulating the gut microbiome with probiotic supplementation or specific dietary patterns could
provide a therapeutic strategy for PWS. Further research is warranted to determine whether meat
consumption modulates intestinal abundance of Alistipes or other microbial taxa impacting obesity
status and metabolic health.
The limitations of this study include that the dietary analysis is based on parental reported food
diaries; while in general the parents and caregivers are well-trained regarding the quality of the diet and
are proficient in filling up food diaries, we cannot exclude potential omissions due to foods consumed
without parental knowledge. Furthermore, all subjects are from a specific geographical area (Catalonia),
and further studies would be necessary to determine whether meat and fruit intake are also associated
with the degree of obesity in patients with PWS from other regions of the world, with different dietary
and lifestyle patterns. Finally, this is a cross-sectional study that describes associations between dietary
variables, gut microbial abundances, and obesity; therefore, causality cannot be inferred.
5. Conclusions
In summary, our results indicate that obesity status and adiposity in children and adolescents
with PWS are not associated with total caloric intake but correlate to higher meat and lower fruit
consumption. Further studies are warranted to determine whether limiting meat and increasing fruit
consumption can provide a strategy for weight control in children with PWS.
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